Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial
10.1186/1475-2840-10-102
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/181621 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-181621 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1816212024-04-25T02:38:23Z Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial Scott, R Donoghoe, M Watts, G.F O'Brien, R Pardy, C Taskinen, M.-R Davis, T.M.E Colman, P.G Manning, P Fulcher, G Keech, A.C SURGERY creatinine fenofibrate hemoglobin A1c high density lipoprotein cholesterol placebo triacylglycerol antilipemic agent fenofibrate glycosylated hemoglobin hemoglobin A1c protein, human high density lipoprotein cholesterol triacylglycerol adult aged article cardiovascular disease cardiovascular risk controlled study creatinine blood level drug efficacy dyslipidemia female human hypertension hypertriglyceridemia kidney dysfunction major clinical study male metabolic syndrome X non insulin dependent diabetes mellitus prevalence randomized controlled trial systolic blood pressure treatment outcome triacylglycerol blood level waist circumference waist hip ratio world health organization Australia blood cardiovascular disease clinical trial cohort analysis controlled clinical trial Finland hypertension metabolic syndrome X metabolism middle aged New Zealand non insulin dependent diabetes mellitus pathophysiology proportional hazards model risk factor Aged Australia Cardiovascular Diseases Cholesterol, HDL Cohort Studies Diabetes Mellitus, Type 2 Female Fenofibrate Finland Hemoglobin A, Glycosylated Humans Hypertension Hypolipidemic Agents Male Metabolic Syndrome X Middle Aged New Zealand Placebos Proportional Hazards Models Risk Factors Triglycerides 10.1186/1475-2840-10-102 Cardiovascular Diabetology 10 102 2020-10-27T11:29:55Z 2020-10-27T11:29:55Z 2011 Article Scott, R, Donoghoe, M, Watts, G.F, O'Brien, R, Pardy, C, Taskinen, M.-R, Davis, T.M.E, Colman, P.G, Manning, P, Fulcher, G, Keech, A.C (2011). Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial. Cardiovascular Diabetology 10 : 102. ScholarBank@NUS Repository. https://doi.org/10.1186/1475-2840-10-102 14752840 https://scholarbank.nus.edu.sg/handle/10635/181621 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
creatinine fenofibrate hemoglobin A1c high density lipoprotein cholesterol placebo triacylglycerol antilipemic agent fenofibrate glycosylated hemoglobin hemoglobin A1c protein, human high density lipoprotein cholesterol triacylglycerol adult aged article cardiovascular disease cardiovascular risk controlled study creatinine blood level drug efficacy dyslipidemia female human hypertension hypertriglyceridemia kidney dysfunction major clinical study male metabolic syndrome X non insulin dependent diabetes mellitus prevalence randomized controlled trial systolic blood pressure treatment outcome triacylglycerol blood level waist circumference waist hip ratio world health organization Australia blood cardiovascular disease clinical trial cohort analysis controlled clinical trial Finland hypertension metabolic syndrome X metabolism middle aged New Zealand non insulin dependent diabetes mellitus pathophysiology proportional hazards model risk factor Aged Australia Cardiovascular Diseases Cholesterol, HDL Cohort Studies Diabetes Mellitus, Type 2 Female Fenofibrate Finland Hemoglobin A, Glycosylated Humans Hypertension Hypolipidemic Agents Male Metabolic Syndrome X Middle Aged New Zealand Placebos Proportional Hazards Models Risk Factors Triglycerides |
| spellingShingle |
creatinine fenofibrate hemoglobin A1c high density lipoprotein cholesterol placebo triacylglycerol antilipemic agent fenofibrate glycosylated hemoglobin hemoglobin A1c protein, human high density lipoprotein cholesterol triacylglycerol adult aged article cardiovascular disease cardiovascular risk controlled study creatinine blood level drug efficacy dyslipidemia female human hypertension hypertriglyceridemia kidney dysfunction major clinical study male metabolic syndrome X non insulin dependent diabetes mellitus prevalence randomized controlled trial systolic blood pressure treatment outcome triacylglycerol blood level waist circumference waist hip ratio world health organization Australia blood cardiovascular disease clinical trial cohort analysis controlled clinical trial Finland hypertension metabolic syndrome X metabolism middle aged New Zealand non insulin dependent diabetes mellitus pathophysiology proportional hazards model risk factor Aged Australia Cardiovascular Diseases Cholesterol, HDL Cohort Studies Diabetes Mellitus, Type 2 Female Fenofibrate Finland Hemoglobin A, Glycosylated Humans Hypertension Hypolipidemic Agents Male Metabolic Syndrome X Middle Aged New Zealand Placebos Proportional Hazards Models Risk Factors Triglycerides Scott, R Donoghoe, M Watts, G.F O'Brien, R Pardy, C Taskinen, M.-R Davis, T.M.E Colman, P.G Manning, P Fulcher, G Keech, A.C Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial |
| description |
10.1186/1475-2840-10-102 |
| author2 |
SURGERY |
| author_facet |
SURGERY Scott, R Donoghoe, M Watts, G.F O'Brien, R Pardy, C Taskinen, M.-R Davis, T.M.E Colman, P.G Manning, P Fulcher, G Keech, A.C |
| format |
Article |
| author |
Scott, R Donoghoe, M Watts, G.F O'Brien, R Pardy, C Taskinen, M.-R Davis, T.M.E Colman, P.G Manning, P Fulcher, G Keech, A.C |
| author_sort |
Scott, R |
| title |
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial |
| title_short |
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial |
| title_full |
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial |
| title_fullStr |
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial |
| title_full_unstemmed |
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial |
| title_sort |
impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial |
| publishDate |
2020 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/181621 |
| _version_ |
1800914646020915200 |